ARTICLE 6 ANALYSIS OF SAMPLES
Doping Control Samples collected under these Anti-Doping Rules shall be analyzed in accordance with the following principles:
6.1 Use of Approved Laboratories
For purposes of Article 2.1, IFS shall send Doping Control Samples for analysis only to WADA-accredited laboratories or as otherwise approved by WADA. The choice of the WADA-accredited laboratory (or other laboratory or method approved by WADA) used for the Sample analysis shall be determined exclusively by IFS.
6.2 Purpose of Collection and Analysis of Samples
Samples shall be analyzed to detect Prohibited Substances and Prohibited Methods identified on the Prohibited List and other substances as may be directed by WADA pursuant to the Monitoring Program described in Article 4.5 of the Code or to assist IFS in profiling relevant parameters in an Athlete’s urine, blood or other matrix, including DNA or genomic profiling, for anti-doping purposes.
6.3 Research on Samples
No Sample may be used for any purpose other than as described in Article 6.2 without the Athlete's written consent. Samples used (with the Athlete’s consent) for purposes other than Article 6.2 shall have any means of identification removed such that they cannot be traced back to a particular Athlete.
6.4 Standards for Sample Analysis and Reporting
Laboratories shall analyze Doping Control Samples and report results in conformity with the International Standard for Laboratories.
6.5 Retesting Samples
A Sample may be reanalyzed for the purposes described in Article 6.2 at any time exclusively at the direction of IFS or WADA. The circumstances and conditions for retesting Samples shall conform with the requirements of the International Standard for Laboratories.